Orphan medicines, advances, access and affordabilityLONDON, UNITED KINGDOM, April 19th 2017: The number of orphan drug candidates gaining European market authorisation has risen Share XOrphan medicines, advances, access and affordabilityhttps://pharmaphorum.com/partner-content-market-access/orphan-medicines-advances-access-affordability/
